Patent US4893627A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4893627A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for nuclear magnetic resonance imaging using deuterum as a contrast agent

Assignee: United States Department of Energy
•
Filing: 1988-05-26
•
Granted: 1990-01-16
•
Expires: 2008-05-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for in vivo NMR imaging of the blood vessels and organs of a patient characterized by using a dark dye-like imaging substance consisting essentially of a stable, high-purity concentration of D 2 O in a solution with water.

Inventors

  • 👤 Joseph J. Kehayias
  • 👤 Darrel D. Joel
  • 👤 William H. Adams
  • 👤 Harry L. Stein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 01:24
CPC Classifications
A; A61; A61K; A61K49/00; A61K49/06; A61K49/18; Y; Y10; Y10T; Y10T436/00; Y10T436/24

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 112 words
A method for in vivo NMR imaging consisting of positioning a patient within the magnetic field of an energized NMR system, administering an acceptable NMR imaging amount of stable, high-purity D 2 O in isosmotic water solution by injecting the solution through a catheter into a blood vessel of the patient, said acceptable amount of D 2 O being sufficient to enable the administered D 2 O to form dark dye-like images as the solution is subjected to the H-1 resonance of the system, said H-1 resonance being effected at a frequency at which D 2 O will not resonate, detecting H-1 resonance signals, and processing said signals to provide an image.
Claim 2
Independent Claim 112 words
A method for in vivo NMR imaging consisting of positioning a patient within the magnetic field of an energized NMR system, administering an acceptable NMR imaging amount of stable, high-purity D 2 O in isosmotic water solution by injecting the solution through a catheter into a blood vessel of the patient, said acceptable amount of D 2 O being sufficient to enable the administered D 2 O to form dark dye-like images as the solution is subjected to the H-1 resonance of the system, said H-1 resonance being effected at a frequency at which D 2 O will not resonate, detecting H-1 resonance signals, and processing said signals to provide an image.
Claim 3
Dependent Claim 66 words
An NMR imaging method comprising using a dense solution of D 2 O and H 2 O as an imaging dye said dense solution of D 2 O and H 2 O having a ratio of D 2 O/H 2 O equal to at least 99.00% by weight D 2 O, causing H-1 resonance, detecting H-1 resonance signals, and processing said signals to provide an image.
Claim 4
Dependent Claim 66 words
An NMR imaging method comprising using a dense solution of D 2 O and H 2 O as an imaging dye said dense solution of D 2 O and H 2 O having a ratio of D 2 O/H 2 O equal to at least 99.00% by weight D 2 O, causing H-1 resonance, detecting H-1 resonance signals, and processing said signals to provide an image.

References Cited (Backward Citations)

US3576994A Cited
US4070611A Cited
US4523596A Cited
US4586511A Cited
US4746507A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-01-15 1993-07-17 1994-01-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-01-15 1997-07-17 1998-01-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-01-15 2001-07-17 2002-01-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag